Mercer Global Advisors »

Ultragenyx Pharmaceutical shares owned by Mercer Global Advisors

Quarter-by-quarter ownership of Ultragenyx Pharmaceutical (RARE) shares owned by Mercer Global Advisors from 13F filings

Historical chart of Mercer Global Advisors investment in Ultragenyx Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Ultragenyx Pharmaceutical held by Mercer Global Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ultragenyx Pharmaceutical by Mercer Global Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $708k 34k 20.95
2025-12-31 $321k 14k 23.00
2025-09-30 $359k 12k 30.08

More positions owned by Mercer Global Advisors

Ishares Tr Core Us Aggbd Et (AGG)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Dimensional Etf Trust Us Mktwide Value (DFUV)
Ishares Tr Msci Usa Mmentm (MTUM)
Dimensional Etf Trust Us High Profitab (DUHP)
Vanguard Charlotte Fds Total Int Bd Etf (BNDX)
Apple (AAPL)
Dimensional Etf Trust Intl Core Equity (DFIC)
NVIDIA Corporation (NVDA)
Dimensional Etf Trust Internatnal Val (DFIV)
Ishares Tr Msci Intl Moment (IMTM)
Dimensional Etf Trust Intl High Profit (DIHP)

View all positions for Mercer Global Advisors

Top funds holding Ultragenyx Pharmaceutical

Vanguard Group
BlackRock
Vanguard Portfolio Management
AQR Capital Management
State Street Corporation
Vanguard Capital Management
Sofinnova Ventures
Sands Capital Management
Rtw Investments
FMR
Wellington Management Company
Citadel Advisors
Assenagon Asset Management
Two Sigma Investments
Frontier Capital Management

View all funds holding Ultragenyx Pharmaceutical